An obesity- and aging-associated decline in NAD+ content and SIRT2 activity in hypothalamic microglia might exaggerate microglial activation and hypothalamic inflammation and accelerate systemic aging and obesity. The gene discussed is SIRT2; the disease is obesity disorder.